Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 80(12): 2651-2662, 2020 06 15.
Article in English | MEDLINE | ID: mdl-32291318

ABSTRACT

Ceramide-induced endothelial cell apoptosis boosts intestinal stem cell radiosensitivity. However, the molecular connection between these two cellular compartments has not been clearly elucidated. Here we report that ceramide and its related enzyme acid sphingomyelinase (ASM) are secreted by irradiated endothelial cells and act as bystander factors to enhance the radiotoxicity of intestinal epithelium. Ceramide and the two isoforms of ASM were acutely secreted in the blood serum of wild-type mice after 15 Gy radiation dose, inducing a gastrointestinal syndrome. Interestingly, serum ceramide was not enhanced in irradiated ASMKO mice, which are unable to develop intestinal failure injury. Because ASM/ceramide were secreted by primary endothelial cells, their contribution was studied in intestinal epithelium dysfunction using coculture of primary endothelial cells and intestinal T84 cells. Adding exogenous ASM or ceramide enhanced epithelial cell growth arrest and death. Conversely, blocking their secretion by endothelial cells using genetic, pharmacologic, or immunologic approaches abolished intestinal T84 cell radiosensitivity. Use of enteroid models revealed ASM and ceramide-mediated deleterious mode-of-action: when ceramide reduced the number of intestinal crypt-forming enteroids without affecting their structure, ASM induced a significant decrease of enteroid growth without affecting their number. Identification of specific and different roles for ceramide and ASM secreted by irradiated endothelial cells opens new perspectives in the understanding of intestinal epithelial dysfunction after radiation and defines a new class of potential therapeutic radiomitigators. SIGNIFICANCE: This study identifies secreted ASM and ceramide as paracrine factors enhancing intestinal epithelial dysfunction, revealing a previously unknown class of mediators of radiosensitivity.


Subject(s)
Ceramides/metabolism , Endothelial Cells/metabolism , Intestinal Mucosa/pathology , Radiation Injuries/pathology , Sphingomyelin Phosphodiesterase/metabolism , Animals , Bystander Effect/radiation effects , Cells, Cultured , Ceramides/blood , Coculture Techniques , Desipramine/pharmacology , Disease Models, Animal , Endothelial Cells/drug effects , Endothelial Cells/radiation effects , Epithelial Cells/drug effects , Epithelial Cells/pathology , Epithelial Cells/radiation effects , Humans , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/radiation effects , Male , Mice , Mice, Knockout , Paracrine Communication/genetics , Paracrine Communication/radiation effects , Primary Cell Culture , RNA, Small Interfering/metabolism , Radiation Injuries/blood , Radiation Injuries/etiology , Radiation Injuries/prevention & control , Radiation Tolerance/drug effects , Radiation Tolerance/genetics , Sphingomyelin Phosphodiesterase/antagonists & inhibitors , Sphingomyelin Phosphodiesterase/blood , Sphingomyelin Phosphodiesterase/genetics
2.
Cell Signal ; 33: 10-21, 2017 05.
Article in English | MEDLINE | ID: mdl-28179144

ABSTRACT

The p38 MAPK signaling pathway is essential in the cellular response to stress stimuli, in particular in the endothelial cells that are major target of external stress. The importance of the bioactive sphingolipid ceramide generated by acid sphingomyelinase is also firmly established in stress-induced endothelial apoptotic cell death. Despite a suggested link between the p38 MAPK and ceramide pathways, the exact molecular events of this connection remain elusive. In the present study, by using two different activators of p38 MAPK, namely anisomycin and ionizing radiation, we depicted how ceramide generated by acid sphingomyelinase was involved in p38 MAPK-dependent apoptosis of endothelial cells. We first proved that both anisomycin and ionizing radiation conducted to apoptosis through activation of p38 MAPK in human microvascular endothelial cells HMEC-1. We then found that both treatments induced activation of acid sphingomyelinase and the generation of ceramide. This step was required for p38 MAPK activation and apoptosis. We finally showed that irradiation, as well as treatment with exogenous C16-ceramide or bacterial sphingomyelinase, induced in endothelial cells a deep reorganization of the plasma membrane with formation of large lipid platforms at the cell surface, leading to p38 MAPK activation and apoptosis in endothelial cells. Altogether, our results proved that the plasma membrane reorganization leading to ceramide production is essential for stress-induced activation of p38 MAPK and apoptosis in endothelial cells and established the link between the acid sphingomyelinase/ceramide and p38 MAPK pathways.


Subject(s)
Apoptosis , Cell Membrane/metabolism , Ceramides/metabolism , MAP Kinase Signaling System , Sphingomyelin Phosphodiesterase/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Endothelial Cells/metabolism , Enzyme Activation , Humans , Membrane Microdomains/metabolism , Models, Biological , Stress, Physiological
3.
Radiother Oncol ; 119(2): 229-35, 2016 05.
Article in English | MEDLINE | ID: mdl-27113798

ABSTRACT

BACKGROUND AND PURPOSES: Early biomarkers of tumour response are needed to discriminate between responders and non-responders to radiotherapy. We evaluated the ability of ceramide, a bioactive sphingolipid, to predict tumour sensitivity in patients treated by hypofractionated stereotactic body radiation therapy (SBRT) combined with irinotecan chemotherapy. MATERIALS AND METHODS: Plasma levels of total ceramide and of its subspecies were measured before and during treatment in 35 patients with liver and lung oligometastases of colorectal cancer included in a phase II trial. Cer levels were quantified by LC-ESI-MS/MS and compared to tumour volume response evaluated one year later by CT-scan. RESULTS: Pretreatment plasma ceramide levels were not indicative of tumour response. Nevertheless, the levels of total ceramide and of its 4 main subspecies were significantly higher at days 3 and 10 of treatment in objective responders than in non-responders. According to Kaplan-Meier curves, almost complete tumour control was achieved at 1year in patients with increased total ceramide levels whereas 50% of patients with decreased levels experienced an increase in tumour volume. CONCLUSIONS: Total plasma ceramide is a promising biomarker of tumour response to SBRT combined with irinotecan that should enable to segregate patients with high risk of tumour escape.


Subject(s)
Camptothecin/analogs & derivatives , Ceramides/blood , Liver Neoplasms/radiotherapy , Lung Neoplasms/radiotherapy , Radiation-Sensitizing Agents/therapeutic use , Radiosurgery/methods , Adult , Aged , Biomarkers/blood , Camptothecin/therapeutic use , Combined Modality Therapy , Female , Humans , Irinotecan , Kaplan-Meier Estimate , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Male , Middle Aged , Radiosurgery/adverse effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...